Think they said in the PR " in the next eighteen months" for the uplist, but that was pre covid. If Dent is true to his word, and my $$ say he is,no RS to get to that $5 SP required for uplist. That's going to be a steep hill if done organically, but once there it will see a whole different level of people coming in. Smart folks won't touch OTC's for good reasons, plus you can't margin them. I think by spring this company will have a much wider appeal to it.
News 
Market Data 
Discover 
